🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Wei Xue

Shanghai Jiao Tong University

ORCID: 0000-0002-5566-8329

Also affiliated with University of Florida, Integrated Plant Genetics (United States), Children's Oncology Group, Florida College

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 6%percentile

0.276Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Extremity rhabdomyosarcoma in children, adolescents and young adults: A report from Children's Oncology Group trials

Cancer(2025)10.1002/cncr.35929

Top 57%

0.276DataRank

Top 57%5 citations

Wei Xue, Amira Qumseya, Thomas J. Scharschmidt, Odion Binitie, Joel Sorger +7 more

Papers

Driven by 14 papers — median percentile 43. Top paper: “Addition of temsirolimus to chemotherapy in children, adolescents, and young adults with intermediate-risk rhabdomyosarcoma (ARST1431): a randomised, open-label, phase 3 trial from the Children's Oncology Group”.

Addition of temsirolimus to chemotherapy in children, adolescents, and young adults with intermediate-risk rhabdomyosarcoma (ARST1431): a randomised, open-label, phase 3 trial from the Children's Oncology Group

The Lancet Oncology(2024)10.1016/s1470-2045(24)00255-9

N/A

0.907DataRank · unranked

43 citations

Wei Xue, Douglas J Harrison, Douglas S. Hawkins, Roshni Dasgupta, Suzanne Wolden +10 more

Extremity rhabdomyosarcoma in children, adolescents and young adults: A report from Children's Oncology Group trials

Cancer(2025)10.1002/cncr.35929

Top 57%

0.276DataRank

Top 57%5 citations

Wei Xue, Amira Qumseya, Thomas J. Scharschmidt, Odion Binitie, Joel Sorger +7 more

Closed-Loop, Cervical, Epidural Stimulation Elicits Respiratory Neuroplasticity after Spinal Cord Injury in Freely Behaving Rats

eNeuro(2022)10.1523/eneuro.0426-21.2021

N/A

0DataRank · unranked

15 citations

Mia N. Kelly, Rachel L. Nosacka, Marissa A. Nash, Sijia Yue, Wei Xue +3 more

Survival of patients with orbital and eyelid rhabdomyosarcoma treated on Children's Oncology Group studies from 1997 to 2013: A report from the Children's Oncology Group

Cancer(2023)10.1002/cncr.34723

N/A

0DataRank · unranked

12 citations

Wei Xue, Zhengya Gao, Ralph P. Ermoian, Julie A. Bradley, Michael Arnold +4 more

Rhabdomyosarcoma with isolated lung metastases: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group

Pediatric Blood & Cancer(2023)10.1002/pbc.30293

N/A

0DataRank · unranked

11 citations

Leo Y. Luo, Susan M. Hiniker, Daniel S. Rhee, Roshni Dasgupta, Sonja Chen +5 more

Adolescents and young adults with rhabdomyosarcoma: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group

Pediatric Blood & Cancer(2024)10.1002/pbc.30847

N/A

0DataRank · unranked

11 citations

Amira Qumseya, Wei Xue, Michael Arnold, Timothy B. Lautz, Susan M. Hiniker +5 more

Event‐free survival in relapsed and refractory rhabdomyosarcoma treated on cooperative group phase II trials: A report from the Children's Oncology Group

Pediatric Blood & Cancer(2024)10.1002/pbc.31009

N/A

0DataRank · unranked

7 citations

Wei Xue, Zhengya Gao, Sapna Oberoi, Aaron R. Weiss, Rajkumar Venkatramani +2 more

Late Events Occurring After 5 Years in Pediatric Rhabdomyosarcoma: A Report From the Children's Oncology Group

Pediatric Blood & Cancer(2024)10.1002/pbc.31421

N/A

0DataRank · unranked

4 citations

Wei Xue, Amira Qumseya, Timothy B. Lautz, Archana Shenoy, Susan M. Hiniker +4 more

Embryonal sarcoma of the liver in pediatric and young adult patients: A report from Children’s Oncology Group study ARST0332

Cancer(2024)10.1002/cncr.35305

N/A

0DataRank · unranked

7 citations

Wei Xue, Zhengya Gao, Andrea Hayes Dixon, Lynn Million, Stephanie F. Polites +10 more

Outcomes for patients with perineal and perianal rhabdomyosarcoma: A report from the Children's Oncology Group Soft Tissue Sarcoma Committee

Pediatric Blood & Cancer(2024)10.1002/pbc.31303

N/A

0DataRank · unranked

2 citations

Wei Xue, Andrea Hayes Dixon, Suzanne L. Wolden, Torunn I. Yock, Rajkumar Venkatramani +2 more

Radiation Therapy Dose Escalation Failed to Improve Local Control for Intermediate-Risk Rhabdomyosarcoma on ARST1431: A Report From the Children’s Oncology Group

International Journal of Radiation Oncology*Biology*Physics(2025)10.1016/j.ijrobp.2025.03.038

N/A

0DataRank · unranked

6 citations

Wei Xue, Abha A. Gupta, Amira Qumseya, Roshni Dasgupta, Christine E. Hill‐Kayser +6 more

Increased risk for COVID-19 in patients with vitamin D deficiency

Nutrition(2020)10.1016/j.nut.2020.111106

N/A

0DataRank · unranked

100 citations

Sijia Yue, Wei Xue, Joseph Katz

Intraoperative phrenic nerve stimulation to prevent diaphragm fiber weakness during thoracic surgery

PLoS ONE(2025)10.1371/journal.pone.0320936

N/A

0DataRank · unranked

1 citations

Thomas M. Beaver, A. Daniel Martin, Robbert van der Pijl, Robert T. Mankowski, Christiaan Leeuwenburgh +9 more

Suboptimal outcome for patients with biliary rhabdomyosarcoma treated on low‐risk clinical trials: A report from the Children's Oncology Group

Pediatric Blood & Cancer(2021)10.1002/pbc.28914

N/A

0DataRank · unranked

19 citations

Wei Xue, Joshua D. Palmer, David Walterhouse, Michael Arnold, Todd E. Heaton +2 more